These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15030433)

  • 21. Left atrial appendage occlusion eliminates the need for warfarin.
    Holmes DR; Schwartz RS
    Circulation; 2009 Nov; 120(19):1919-26; discussion 1926. PubMed ID: 19901202
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of stroke in atrial fibrillation].
    Masjuan J
    Neurologia; 2012 Mar; 27 Suppl 1():1-3. PubMed ID: 22682203
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefits of left atrial appendage occlusion for stroke prevention.
    Stöllberger C; Schneider B; Finsterer J
    Am Heart J; 2006 Jun; 151(6):e1; author reply e3. PubMed ID: 16781207
    [No Abstract]   [Full Text] [Related]  

  • 24. Stroke prevention by means of left atrial appendage strangulation?
    Stöllberger C; Schneider B; Finsterer J
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):732. PubMed ID: 20723748
    [No Abstract]   [Full Text] [Related]  

  • 25. Left atrial appendage occlusion does not eliminate the need for warfarin.
    Whitlock RP; Healey JS; Connolly SJ
    Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203
    [No Abstract]   [Full Text] [Related]  

  • 26. [Surgical closure of the left atrial appendage in patients with atrial fibrillation. Indications, techniques and results].
    Hanke T; Sievers HH; Doll N; Weimar T
    Herzschrittmacherther Elektrophysiol; 2013 Mar; 24(1):53-7. PubMed ID: 23549987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonpharmacologic stroke prevention in atrial fibrillation.
    Onalan O; Lashevsky I; Hamad A; Crystal E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):619-33. PubMed ID: 16076273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Left atrial appendage closure in atrial fibrillation].
    Fauchier L; Taillandier S; Clementy N
    Rev Prat; 2013 Feb; 63(2):205. PubMed ID: 23513783
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral Embolic Protection Device During Transcatheter Mitral Valve-in-Valve Implantation in a Patient With Left Atrial Appendage Thrombosis.
    Di Maio S; Melillo F; Ancona MB; Vella C; Fiore G; Agricola E; Montorfano M
    Can J Cardiol; 2022 Jan; 38(1):133-134. PubMed ID: 34688852
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of a novel device for left atrial appendage exclusion: the second-generation atrial exclusion device.
    Kamohara K; Fukamachi K; Ootaki Y; Akiyama M; Cingoz F; Ootaki C; Vince DG; Popović ZB; Kopcak MW; Dessoffy R; Liu J; Gillinov AM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):340-6. PubMed ID: 16872960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Images in cardiology. Computed tomography in a patient after percutaneous left atrial appendage transcatheter occlusion (PLAATO).
    Mohrs OK; Ruebesam D; Peters J
    Heart; 2006 Apr; 92(4):486. PubMed ID: 16537763
    [No Abstract]   [Full Text] [Related]  

  • 33. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 34. Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation.
    Ramondo A; Maiolino G; Napodano M; Isabella G; Tarantini G; Bonato R; Pengo V; Ponchia A; Iliceto S
    Ital Heart J; 2005 May; 6(5):414-7. PubMed ID: 15934416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale of cerebral protection devices in left atrial appendage occlusion.
    Meincke F; Spangenberg T; Kreidel F; Frerker C; Virmani R; Ladich E; Kuck KH; Ghanem A
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):154-158. PubMed ID: 27762092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of embolic stroke by catheter ablation of atrial fibrillation.
    Stöllberger C; Schneider B; Winkler-Dworak M; Finsterer J
    Eur J Neurol; 2008 Dec; 15(12):1419-20. PubMed ID: 19049566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WATCHMAN matches warfarin.
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):456. PubMed ID: 19419252
    [No Abstract]   [Full Text] [Related]  

  • 38. [Feasibility of percutaneous exclusion of the left atrial appendage: results of 11 cases].
    Himbert D; Cachier A; Brochet E; Majdoub M; Olivot JM; Lavallée P; Serfaty JM; Amarenco P; Vahanian A
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):585-92. PubMed ID: 16878719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stroke in a patient with a surgically ligated left atrial appendage: should warfarin be continued after left atrial appendage ligation?
    Kanjwal K; Colyer WR
    Am J Ther; 2011 Jul; 18(4):e117-8. PubMed ID: 20093925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical left atrial appendage occlusion: evaluation of a novel device with magnetic resonance imaging.
    Salzberg SP; Gillinov AM; Anyanwu A; Castillo J; Filsoufi F; Adams DH
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):766-70. PubMed ID: 18693117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.